Fetterman appealed to President Trump and Health and Human Services Secretary Robert F. Kennedy Jr. personally.

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

As counterfeit Ozempic circulates in the U.S., the Food and Drug Administration has issued a warning to Americans. In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

The Trump administration announced Friday it will not move forward with plans to cover popular weight-loss drugs under ...

Donald Trump’s team gutted the Biden administration’s plan as part of a sprawling 438-page regulation update that tweaks how beneficiaries get drug coverage ...